Dolizem diltiazem cream: Development discontinued

Assembly said it will not pursue further development of VEN 307 and ended a March 2007 deal with S.L.A. Pharma granting Assembly exclusive,

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE